BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12033778)

  • 21. Effects of repeated respiratory syncytial virus infections on pulmonary dendritic cells in a murine model of allergic asthma.
    Hirose H; Matsuse H; Fukahori S; Tsuchida T; Tomari S; Kawano T; Fukushima C; Mizuta Y; Kohno S
    Int Arch Allergy Immunol; 2008; 147(3):197-205. PubMed ID: 18594149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
    Johnson TR; Graham BS
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory syncytial virus enhances respiratory allergy in mice despite the inhibitory effect of virus-induced interferon-gamma.
    Barends M; Boelen A; de Rond L; Dormans J; Kwakkel J; van Oosten M; Neijens HJ; Kimman TG
    J Med Virol; 2003 Jan; 69(1):156-62. PubMed ID: 12436492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response.
    Hoffman SJ; Laham FR; Polack FP
    Microbes Infect; 2004 Jul; 6(8):767-72. PubMed ID: 15207824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation.
    Barends M; Van Oosten M; De Rond CG; Dormans JA; Osterhaus AD; Neijens HJ; Kimman TG
    J Infect Dis; 2004 May; 189(10):1866-72. PubMed ID: 15122523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice.
    Tregoning JS; Yamaguchi Y; Harker J; Wang B; Openshaw PJ
    J Virol; 2008 Apr; 82(8):4115-24. PubMed ID: 18272579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.
    Rutigliano JA; Rock MT; Johnson AK; Crowe JE; Graham BS
    Virology; 2005 Jul; 337(2):335-43. PubMed ID: 15916793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.
    Piedimonte G
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S66-74; discussion S74-5. PubMed ID: 12671455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of splenectomy on antiviral T cell memory in mice.
    Mrusek S; Vallbracht S; Ehl S
    Int Immunol; 2005 Jan; 17(1):27-33. PubMed ID: 15520043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma.
    Kondo Y; Matsuse H; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Kohno S
    Clin Exp Allergy; 2004 Aug; 34(8):1307-13. PubMed ID: 15298574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune and functional role of nitric oxide in a mouse model of respiratory syncytial virus infection.
    Stark JM; Khan AM; Chiappetta CL; Xue H; Alcorn JL; Colasurdo GN
    J Infect Dis; 2005 Feb; 191(3):387-95. PubMed ID: 15633098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age and sex as factors of response to RSV infections among those with previous history of wheezing.
    Nagayama Y; Tsubaki T; Sawada K; Taguchi K; Nakayama S; Toba T
    Pediatr Allergy Immunol; 2006 Aug; 17(5):376-81. PubMed ID: 16846457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory syncytial virus persistence: evidence in the mouse model.
    Mejías A; Chávez-Bueno S; Gómez AM; Somers C; Estripeaut D; Torres JP; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S60-2. PubMed ID: 18820580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of respiratory syncytial virus infection in the murine model.
    Peebles RS; Graham BS
    Proc Am Thorac Soc; 2005; 2(2):110-5. PubMed ID: 16113477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection.
    Tripp RA; Barskey A; Goss L; Anderson LJ
    J Neuroimmunol; 2002 Aug; 129(1-2):141-53. PubMed ID: 12161030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory syncytial virus induces phosphorylation of mTOR at ser2448 in CD8 T cells from nasal washes of infected infants.
    de Souza AP; de Freitas DN; Antuntes Fernandes KE; D'Avila da Cunha M; Antunes Fernandes JL; Benetti Gassen R; Fazolo T; Pinto LA; Scotta M; Mattiello R; Pitrez PM; Bonorino C; Stein RT
    Clin Exp Immunol; 2016 Feb; 183(2):248-57. PubMed ID: 26437614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory syncytial virus immunobiology and pathogenesis.
    Graham BS; Rutigliano JA; Johnson TR
    Virology; 2002 May; 297(1):1-7. PubMed ID: 12083830
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenesis of respiratory syncytial virus.
    van Drunen Littel-van den Hurk S; Watkiss ER
    Curr Opin Virol; 2012 Jun; 2(3):300-5. PubMed ID: 22709517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited Immunopathology.
    Liu J; Haddad EK; Marceau J; Morabito KM; Rao SS; Filali-Mouhim A; Sekaly RP; Graham BS
    PLoS Pathog; 2016 Mar; 12(3):e1005486. PubMed ID: 26943673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic interleukin-6 response to respiratory syncytial virus infection.
    Resch B; Müller W
    Pediatr Infect Dis J; 2009 Oct; 28(10):932-3. PubMed ID: 20118689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.